FDAnews
www.fdanews.com/articles/205159-moderna-teams-up-with-metagenomi-for-crispr-research

Moderna Teams Up with Metagenomi for CRISPR Research

November 3, 2021

Moderna has partnered with gene-editing biotech Metagenomi to develop therapeutics for patients with serious genetic diseases.

Under the multiyear collaboration, the companies will leverage Metagenomi’s CRISPR and other gene editing-based platforms and Moderna’s messenger RNA-based and nanoparticle delivery technologies.

Metagenomi will receive an undisclosed upfront payment, along with an equity investment, research funding and milestones-based payments for unspecified disease targets.

View today's stories